{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T10:28:35Z","timestamp":1758709715758,"version":"3.44.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.jid.2017.12.002","type":"journal-article","created":{"date-parts":[[2017,12,13]],"date-time":"2017-12-13T13:17:14Z","timestamp":1513171034000},"page":"1209-1212","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Identification of Atorvastatin for Moderate to\u00a0Severe Hidradenitis through Drug Repositioning Using Public Gene Expression\u00a0Datasets"],"prefix":"10.1016","volume":"138","author":[{"given":"Karen Y.","family":"Kuo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyunje Grace","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kavita Y.","family":"Sarin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2017.12.002_bib1","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.jid.2016.03.001","article-title":"Identification of alpha-adrenergic agonists as potential therapeutic agents for dermatomyositis through drug-repurposing using public expression datasets","volume":"136","author":"Cho","year":"2016","journal-title":"J\u00a0Invest Dermatol"},{"issue":"Web Server issue","key":"10.1016\/j.jid.2017.12.002_bib2","doi-asserted-by":"crossref","first-page":"W449","DOI":"10.1093\/nar\/gku476","article-title":"LINCS Canvas Browser: interactive web app to query, browse and interrogate LINCS L1000 gene expression signatures","volume":"42","author":"Duan","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jid.2017.12.002_bib3","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1592\/phco.31.11.1045","article-title":"Atorvastatin for the treatment of plaque-type psoriasis","volume":"31","author":"Faghihi","year":"2011","journal-title":"Pharmacotherapy"},{"issue":"Suppl. 1","key":"10.1016\/j.jid.2017.12.002_bib4","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1007\/s00586-005-1044-x","article-title":"Pain assessment","volume":"15","author":"Haefeli","year":"2006","journal-title":"Eur Spine J"},{"issue":"S1.AB45","key":"10.1016\/j.jid.2017.12.002_bib5","first-page":"631","article-title":"Safety and efficacy of adalimumab in patients with severe hidradenitis suppurativa: results from PIONEER II, a phase 3 randomized, placebo-controlled trial","volume":"72","author":"Jemec","year":"2015","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2017.12.002_bib6","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1111\/bjd.13270","article-title":"Assessing the validity, responsiveness and meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment","volume":"171","author":"Kimball","year":"2014","journal-title":"Br J Dermatol"},{"issue":"Suppl. 1","key":"10.1016\/j.jid.2017.12.002_bib7","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.jaad.2015.07.055","article-title":"Systemic associations of hidradenitis suppurativa","volume":"73","author":"Kohorst","year":"2015","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2017.12.002_bib8","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1159\/000247363","article-title":"Generalized eczematous skin rash possibly due to HMG-CoA reductase inhibitors","volume":"186","author":"Krasovec","year":"1993","journal-title":"Dermatology"},{"issue":"5795","key":"10.1016\/j.jid.2017.12.002_bib9","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1126\/science.1132939","article-title":"The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease","volume":"313","author":"Lamb","year":"2006","journal-title":"Science"},{"issue":"21","key":"10.1016\/j.jid.2017.12.002_bib10","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.97071","article-title":"Combined inhibition of atypical PKC and histone deacetylase 1 is cooperative in basal cell carcinoma treatment","volume":"7","author":"Mirza","year":"2017","journal-title":"JCI Insight"},{"issue":"5","key":"10.1016\/j.jid.2017.12.002_bib11","doi-asserted-by":"crossref","first-page":"e97009","DOI":"10.1371\/journal.pone.0097009","article-title":"Atorvastatin improves plaque stability in ApoE-knockout mice by regulating chemokines and chemokine receptors","volume":"9","author":"Nie","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2017.12.002_bib12","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/0897190015627255","article-title":"Synergistic benefit of statin and metformin in gastrointestinal malignancies","volume":"30","author":"Nimako","year":"2017","journal-title":"J\u00a0Pharm Pract"},{"key":"10.1016\/j.jid.2017.12.002_bib13","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1046\/j.1365-2133.2003.05390.x","article-title":"Suggestions for uniform outcome variables when reporting treatment effects in hidradenitis suppurativa","volume":"149","author":"Sartorius","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2017.12.002_bib14","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/j.1365-2133.2011.10254.x","article-title":"Elevated levels of tumour necrosis factor (TNF)-alpha, interleukin (IL)-1beta and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-alpha and IL-1beta","volume":"164","author":"van der Zee","year":"2011","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jid.2017.12.002_bib15","doi-asserted-by":"crossref","DOI":"10.1111\/aji.12669","article-title":"PAI-1 in granulosa cells is suppressed directly by statin and indirectly by suppressing TGF-beta and TNF-alpha in mononuclear cells by insulin-sensitizing drugs","volume":"78","author":"Yamada-Nomoto","year":"2017","journal-title":"Am J Reprod Immunol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X17332840?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X17332840?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T17:12:07Z","timestamp":1758301927000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X17332840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0022202X17332840"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2017.12.002","relation":{},"ISSN":["0022-202X"],"issn-type":[{"type":"print","value":"0022-202X"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of Atorvastatin for Moderate to\u00a0Severe Hidradenitis through Drug Repositioning Using Public Gene Expression\u00a0Datasets","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2017.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}